MARY SCHOOLCRAFT: Open Payments
NPI 1043667769 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 22 payments from 14 companies in 2025. Trend: 2023 $1,887 · 2024 $1,877 · 2025 $1,561
Food & beverage: $1,360Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $321 |
| Madrigal Pharmaceuticals | 2 | $268 |
| Regeneron Healthcare Solutions, Inc. | 2 | $246 |
| Caris MPI, Inc. | 1 | $137 |
| BeiGene USA, Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $113 |
| Amarin Pharma, Inc. | 1 | $113 |
| Lilly USA, LLC | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
Products named: RYBREVANT, REZDIFFRA, LIBTAYO, MI CANCER SEEK, BRUKINSA, WAYRILZ, Vascepa, TECVAYLI.
Industry payments across TX — which companies pay providers there.
